Literature DB >> 16277888

Potential role of mammalian target of rapamycin inhibitors in breast cancer therapy.

Funda Meric-Bernstam1, Francisco J Esteva.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16277888     DOI: 10.3816/CBC.2005.n.041

Source DB:  PubMed          Journal:  Clin Breast Cancer        ISSN: 1526-8209            Impact factor:   3.225


× No keyword cloud information.
  2 in total

1.  Rapamycin regulates stearoyl CoA desaturase 1 expression in breast cancer.

Authors:  David Luyimbazi; Argun Akcakanat; Priscilla F McAuliffe; Li Zhang; Gopal Singh; Ana Maria Gonzalez-Angulo; Huiqin Chen; Kim-Anh Do; Yuhuan Zheng; Mien-Chie Hung; Gordon B Mills; Funda Meric-Bernstam
Journal:  Mol Cancer Ther       Date:  2010-09-28       Impact factor: 6.261

2.  Comparison of Akt/mTOR signaling in primary breast tumors and matched distant metastases.

Authors:  Argun Akcakanat; Aysegul Sahin; Alexandra N Shaye; Marco A Velasco; Funda Meric-Bernstam
Journal:  Cancer       Date:  2008-06       Impact factor: 6.860

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.